Skip to main content
. 2015 Oct 8;4:30. doi: 10.1186/s40164-015-0026-x

Fig. 4.

Fig. 4

Radiology evaluation of disease burden after imatinib treatment. a PET-CT 4 weeks after initiation of imatinib treatment showing marked interval improvement in supradiaphragmatic and infradiaphragmatic lymphadenopathy as well as the skeletal/marrow disease burden. b PET-CT 6 months post imatinib treatment and 4 months reduced-intensity conditioning allogeneic stem cell transplantation shows no FDG-avid malignancy